G1 Therapeutics Provides Second Quarter 2021 Financial Results and Operational Highlights

NEXT STORY
Allogene Therapeutics Reports Second Quarter 2021 Financial Results
PREV STORY
Sorrento Announces Promising Results in a Publication Detailing of Salicyn-30 and Other Salicylanilides in Reducing SARS-CoV‑2 Replication and Suppressing Induction of Inflammatory Cytokines in a Rodent Model
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer

author_avatar
NASDAQ Market News

Inventiva announces completion of patient visits for its Phase IIb clinical study with lanifibranor in NASH

author_avatar
NASDAQ Market News

AB Science announces that the CHMP has adopted a negative opinion for the marketing authorization of masitinib in Amyotrophic Lateral Sclerosis

author_avatar
NASDAQ Market News